$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Can taking clofazimine and drinking more water alleviate skin darkening?
2026-02-01 22:25:32
Check Details
How many months can you take clofazimine?
2026-02-01 22:25:32
Check Details
Precautions when using clofazimine
2026-02-01 22:25:32
Check Details
Clofazimine side effects and side effects management
2026-02-01 22:25:32
Check Details
How long does it take to become resistant to clofazimine? How to deal with drug resistance?
2026-02-01 22:25:32
Check Details
Is clofazimine a bactericidal or bacteriostatic drug?
2026-02-01 22:25:32
Check Details
Clofazimine causes skin darkening
2026-02-01 22:25:32
Check Details
The difference between clofazimine and cycloserine
2026-02-01 22:25:32
Check Details
Can clofazimine be taken with Aster?
2026-02-01 22:25:32
Check Details
How long should clofazimine be taken?
2026-02-01 22:25:32
Check Details
Veneclat and azacitidine show promise in preventing relapse of high-risk MDS and acute myeloid leukemia
2026-02-01 22:25:32
Check Details
Venetex plus HMA therapy shows encouraging results in high-risk MDS/CMML
2026-02-01 22:25:32
Check Details
1
2
...
645
646
647
648
649
650
651
...
10223
10224
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tivozanib: A Next-Generation Highly Selective VEGFR-Targeted Therapy Explained
2
Capmatinib Clinical Guide: Drug Comparisons, Treatment Strategies, and Combination Therapy Prospects
3
Avatrombopag Complete Guide: Efficacy, Indications, and TPO-RA Drug Comparisons
4
Pralsetinib Clinical Guide: Discontinuation Principles, Drug Comparisons, and Treatment Strategies
5
Venetoclax Clinical Guide: Mechanism, Indications, and Originator vs. Generic Comparison
6
Dabrafenib Clinical Guide: Indications, Combination Strategies, and BRAF Inhibitor Comparisons
7
Elagolix Side Effects and Safety Guide
8
Hetrombopag vs. Avatrombopag: Key Differences Between Two Oral TPO-RAs and Safety Considerations
9
Lytenava: The First FDA-Approved Ophthalmic Bevacizumab Formulation
10
FDA Approves Lytenava: First Ophthalmic Bevacizumab for Wet AMD
11
Simtriyo (Centanafadine): World's First NDSRI ADHD Drug Approved by FDA
12
Lipfendra (Enlicitide): The World's First Oral PCSK9 Inhibitor Approved by FDA